Study of a new albumin source for low albumin or low blood volume
Part of Blood & lymphatic clinical trials.
This trial tests a new form of human albumin made from rice for people who need urgent treatment for low albumin levels (hypoalbuminemia) or low blood volume (hypovolemia). It aims to provide a safe and effective alternative to current albumin treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have low albumin levels or low blood volume that needs immediate treatment
- Your doctor has already decided to give you at least one dose of human albumin as part of your care
- You agree to take part and sign a consent form (you or your legal guardian can sign)
- You are not allergic to any ingredients in the study medicine
- You are not currently participating in another drug trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies low albumin levels in children who are very sick. It tests if giving albumin can help children with conditions like severe infections, breathing problems, heart issues, and other serious diseases.
This trial tests a new protein treatment made from rice to help patients recover from low blood protein levels that sometimes occur after liver surgery. The treatment may help your body heal better after the procedure.
This trial tests whether a personalized long-term albumin (a blood protein medicine) can help people with advanced liver scarring who have fluid in the belly (ascites). It compares the personalized albumin approach to standard care to see if it improves outcomes over time.
This trial tests whether a lower dose of albumin works as well as the standard dose for people with cirrhosis and a type of infection called spontaneous bacterial peritonitis (SBP). It aims to see if the low dose can protect kidney function while reducing side effects and costs.
This trial tests whether giving albumin (a protein in the blood) during and after surgery can help prevent complications in people with stomach cancer. It is for those who have surgery to remove their tumor and have normal or near-normal blood albumin levels before surgery.
This trial tests whether giving albumin (a blood protein) in a personalized dose works better than a standard fixed dose for people with cirrhosis and sepsis-related acute kidney injury. The goal is to find a safer and more effective way to protect kidney function.
Hear when a new Hypoalbuminemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.